07 Jan 2001

Cholipin 50 - España

Updated: 07 Jan 2001

Cholipin 50 grageas

Disquinesias biliares, espasmos biliares. Síndrome post-colecistectomía. Dispepsias por alteración de la secreción biliar. Litiasis biliar no obstructiva.

Cholipin 50 Description, Presentation and Dosage

Cholipin 50 Description

Cholipin 50 Drug Class Description

Colagogos y colereticos en asociacion salvo a05c

Cholipin 50 Drug Description


Cholipin 50 Presentation

Cholipin 50 Presentation

1-2 grageas 3 veces al día, preferentemente antes de las comidas.

Cholipin 50 Manufacturer


Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

IL-17A in Psoriasis

IL-17A in Psoriasis

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Cholipin 50 Dosage

Cholipin 50 Precautions, Reactions and Contraindications

Cholipin 50 Special Precautions

Related Drugs - Gastroenterologia

Back to top